Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
5
self-reported band not used
Founded
2011
15 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
BIOVALENCE TECHNOLOGIES PTE. LTD.Entity record →
UEN201723190D
Legal entities
Show as table · Biovalence Technologies Pte Ltd: 1 registry entity
| BIOVALENCE TECHNOLOGIES PTE. LTD. | UEN 201723190D |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Biovalence Technologies is a recombinant proteomics biotech that wants to make a positive impact on human and animal lives. RetroMAD1 is one of two novel, well-defined chimeric proteins with anti-viral properties that can be given orally. Proof of concept, animal studies and clinical trials in pets have shown RetroMAD1 to be effective in reducing clinical signs and/or death resulting from viral infections due to CDV, CPV2, FeLV, FIV and FIPV.
The company is now generating revenue in the pet healthcare market while saving lives of cats suffering from feline leukemia, feline infectious peritonitis, and puppies from canine parvovirosis. We are touched to continue receiving many cat owners’ and cat shelters’ emails on the positive effect that RetroMAD1 has on their feline family members, thriving with a good quality of life.
In humans, the company has generated data against Herpes, Dengue, AIDS and Ebola. It’s now moving rapidly to work on Covid-19 with partners. Scientists have recently discovered that Sars-CoV2 has a mutation close to that of DENV, HIV, EBOV and FIPV that activates the host cell’s furin protease, allowing rapid invasion.
Specialties
All 7 specialties
- Biopharmaceuticals
- Antiviral therapeutic
- Recombinant proteomics
- Bioprocessing
- Healthcare
- Animal health
- Viral diseases
Related specialties
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG7500A Beach Road; Unit 06-307; Singapore, 199591Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Biovalence Technologies Pte Ltd?
One Singapore entity on ACRA: BIOVALENCE TECHNOLOGIES PTE. LTD. (UEN 201723190D), high confidence.
How many people work at Biovalence Technologies Pte Ltd?
5 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does Biovalence Technologies Pte Ltd have offices?
1 address on record.
Has Biovalence Technologies Pte Ltd raised funding?
None linked to this brand.
What does Biovalence Technologies Pte Ltd list as its specialties?
Seven tags on the brand's own list, among them healthcare and animal health.
Which companies are listed alongside Biovalence Technologies Pte Ltd?
5 profiles list Biovalence Technologies Pte Ltd as a peer — 62nd percentile in Biotechnology Research. It lists ten peers of its own. PANOMIX (SINGAPORE) PTE. LTD. and OmicsHealthTech LLC list it back.